Szkultecka-Dębek M, Drozd M, Wiśniewska N, Drozd K. Adverse events (AE) costs assessed in Poland based on existing Drug Programs – methodology of the project. Curr. Issues Pharm. Med. Sci. [Internet]. 2013 Dec. 30 [cited 2025 May 17];26(4):422-4. Available from: https://czasopisma.umlub.pl/curipms/article/view/1350